111 related articles for article (PubMed ID: 7095894)
1. Establishment and characterization of a human myeloma cell line (KMM-1).
Togawa A; Inoue N; Miyamoto K; Hyodo H; Namba M
Int J Cancer; 1982 May; 29(5):495-500. PubMed ID: 7095894
[TBL] [Abstract][Full Text] [Related]
2. Human plasmacytoma with an unusual karyotype growing in vitro and producing light-chain immunoglobulin.
Karpas A; Fisher P; Swirsky D
Lancet; 1982 Apr; 1(8278):931-3. PubMed ID: 6122771
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of a new human Bence Jones-type myeloma cell line, NOP-2.
Nagai T; Ogura M; Morishita Y; Okumura M; Kato Y; Morishima Y; Hirabayashi N; Ohno R; Saito H
Int J Hematol; 1991 Apr; 54(2):141-9. PubMed ID: 1747447
[TBL] [Abstract][Full Text] [Related]
4. [Establishment and characterization of a human myeloma cell line (KMM-1)].
Togawa A; Inoue N; Shimoda M; Mannoji M; Yawata Y; Miyamoto K; Namba M
Nihon Ketsueki Gakkai Zasshi; 1982 May; 45(3):607-14. PubMed ID: 7136460
[No Abstract] [Full Text] [Related]
5. The establishment of a human myeloma cell line elaborating lambda-light chain protein.
Niho Y; Shibuya T; Yamasaki K; Kimura N
Int J Cell Cloning; 1984 May; 2(3):161-72. PubMed ID: 6429256
[TBL] [Abstract][Full Text] [Related]
6. Establishment of five human myeloma cell lines.
Namba M; Ohtsuki T; Mori M; Togawa A; Wada H; Sugihara T; Yawata Y; Kimoto T
In Vitro Cell Dev Biol; 1989 Aug; 25(8):723-9. PubMed ID: 2768132
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of two human myeloma cell lines secreting kappa light chains.
Eton O; Scheinberg DA; Houghton AN
Leukemia; 1989 Oct; 3(10):729-35. PubMed ID: 2506399
[TBL] [Abstract][Full Text] [Related]
8. IgD myeloma: immunology and ultrastructure.
Ioachim NJ; McKenna PJ; Halperin I; Chung FJ
Ann Clin Lab Sci; 1978; 8(3):209-18. PubMed ID: 418730
[TBL] [Abstract][Full Text] [Related]
9. A human plasma cell line: induction and characterization.
Miller CH; Carbonell A; Peng R; Paglieroni T; MacKenzie MR
Cancer; 1982 May; 49(10):2091-6. PubMed ID: 6804081
[TBL] [Abstract][Full Text] [Related]
10. Characterization of new IgG lambda myeloma plasma cell line (EJM): a further tool in the investigation of the biology of multiple myeloma.
Hamilton MS; Ball J; Bromidge E; Lowe J; Franklin IM
Br J Haematol; 1990 Jul; 75(3):378-84. PubMed ID: 2117464
[TBL] [Abstract][Full Text] [Related]
11. Intracytoplasmic and surface-bound immunoglobulins in "nonsecretory" and Bence-Jones myeloma.
Preud'Homme JL; Hurez D; Danon F; Brouet JC; Seligmann M
Clin Exp Immunol; 1976 Sep; 25(3):428-36. PubMed ID: 822974
[TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of a permanent human IgA2/kappa myeloma cell line.
Lohmeyer J; Hadam M; Santoso S; Förster W; Schulz A; Pralle H
Br J Haematol; 1988 Jul; 69(3):335-43. PubMed ID: 3136791
[TBL] [Abstract][Full Text] [Related]
13. Establishment and phenotypic characterization of three new human myeloma cell lines (U-1957, U-1958, and U-1996).
Jernberg H; Nilsson K; Zech L; Lutz D; Nowotny H; Scheirer W
Blood; 1987 Jun; 69(6):1605-12. PubMed ID: 3580570
[TBL] [Abstract][Full Text] [Related]
14. Myelomonocytic myeloma cell line (LB 84-1).
Durie BG; Grogan TM; Spier C; Vela E; Baum V; Rodriquez MA; Frutiger Y
Blood; 1989 Feb; 73(3):770-6. PubMed ID: 2492835
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a new human multiple myeloma cell line, UMJF-2, which suppresses antibody production by B-lymphocytes in vitro.
Farnen JP; Tyrkus M; Hanson CA; Cody RL; Emerson SG
Leukemia; 1991 Jul; 5(7):574-84. PubMed ID: 1649357
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a new human myeloma cell line, KMS-18, having t(4;14)(p16.3;q32.3) derived from a case phenotypically transformed from Ig A-lambda to BJP-lambda, and associated with hyperammonemia.
Otsuki T; Nakazawa N; Taniwaki M; Yamada O; Sakaguchi H; Wada H; Yawata Y; Ueki A
Int J Oncol; 1998 Mar; 12(3):545-52. PubMed ID: 9472091
[TBL] [Abstract][Full Text] [Related]
17. Human bone marrow stroma-dependent cell line MOLP-5 derived from a patient in leukaemic phase of multiple myeloma.
Matsuo Y; Drexler HG; Nishizaki C; Harashima A; Fukuda S; Kozuka T; Sezaki T; Orita K
Br J Haematol; 2000 Apr; 109(1):54-63. PubMed ID: 10848782
[TBL] [Abstract][Full Text] [Related]
18. Double Bence Jones proteinuria.
Kanoh T; Yago K
Arch Pathol Lab Med; 1990 Sep; 114(9):991-4. PubMed ID: 2117911
[TBL] [Abstract][Full Text] [Related]
19. Induction of CD28 on the new myeloma cell line MOLP-8 with t(11;14)(q13;q32) expressing delta/lambda type immunoglobulin.
Matsuo Y; Drexler HG; Harashima A; Okochi A; Hasegawa A; Kojima K; Orita K
Leuk Res; 2004 Aug; 28(8):869-77. PubMed ID: 15203285
[TBL] [Abstract][Full Text] [Related]
20. A case of lambda type tetramer Bence-Jones proteinemia.
Kozuru M; Benoki H; Sugimoto H; Sakai K; Ibayashi H
Acta Haematol; 1977; 57(6):359-65. PubMed ID: 407767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
